AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE GASTROINTESTINAL SYSTEM

Compositions and Methods for Treating Inflammation Associated with IL-6

GENETICALLY MODIFIED CELLS FOR ALLOGENEIC CELL THERAPY

BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA

COMPOSITIONS AND METHODS OF DISSOLVING BIOFILM TO PROMOTE WOUND HEALING

NUCLEIC ACIDS FOR CELL RECOGNITION AND INTEGRATION

Formulations for Prolonging Gestation and for Complications of Menstruation or Gestation

CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A INHIBITORS

METHODS OF REDUCING MAMMOGRAPHIC BREAST DENSITY AND/OR BREAST CANCER RISK

COMPOUNDS FOR NEUTROPHIL ROS INHIBITION

INHIBITORS OF BRUTON'S TYROSINE KINASE

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

METHOD OF REDUCING PULMONARY EXACERBATIONS IN RESPIRATORY DISEASE PATIENTS

METHODS OF TREATING PAIN

ACYL BENZO[D]THIAZOL-2-AMINE AND THEIR METHODS OF USE

JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO

LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+ CANCER

MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

NOVEL PARTICLE COMPOSITION COMPRISING SIALIC ACID BINDING LIGAND

ORAL NANOPARTICLES FOR BIOACTIVE COMPOUND, AND METHOD OF PREPARING SAME

INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS

NOVEL RECOMBINANT EXOSOME CONTAINING HYALURONIDASE AND USE THEREOF

APTAMER-siRNA FUSIONS

RESTORATION OF THE CFTR FUNCTION BY SPLICING MODULATION

PHARMACEUTICAL COMPOSITION AND USE

EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY OF TUMORS RELAPSED/REFRACTORY TO CHECKPOINT INHIBITORS

EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY OF TUMORS RELAPSED/REFRACTORY TO CHECKPOINT INHIBITORS

EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY OF TUMORS RELAPSED/REFRACTORY TO CHECKPOINT INHIBITORS

EFFICACY OF ANTI-TROP-2-SN-38 ANTIBODY DRUG CONJUGATES FOR THERAPY OF TUMORS RELAPSED/REFRACTORY TO CHECKPOINT INHIBITORS

METHODS FOR TREATING MULTIPLE MYELOMA

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

HIGH SELECTIVE CD229 ANTIGEN BINDING DOMAINS AND METHODS OF USE

ANTI-CD48 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND USES THEREOF

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

Inhibitors of complement factor H

USE OF PROTEIN SEQUENCE CAPABLE OF BINDING TO SUBSTRATE IN PREPARATION OF PRODUCT FOR INHIBITING FIBRIN ASSEMBLY

GENETICALLY MODIFIED PROBIOTICS FOR ORAL DELIVERY OF RENIN-ANGIOTENSIN RELATED THERAPEUTIC PROTEINS AND PEPTIDES

NOVEL COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS

ANTIMICROBIAL COMPOUNDS AND THE METHOD OF USE

MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF

N-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE DERIVATIVES AND USES THEREOF

PYRAZOLE-CONTAINING CBP/CATENIN ANTAGONISTS AND USES THEREOF

NOVEL PYRIMIDINE-2,4-DIAMINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

PYRROLYLACYLPIPERIDYLAMINE COMPOUND AND USE THEREOF

CRYSTALLINE NORPSILOCIN COMPOUNDS

METHODS OF PREPARATION OF ZINGERONE, COMPOSITIONS COMPRISING ZINGERONE, AND USES THEREFOR

HUMANIZED ANTI-PROSTATE -SPECIFIC MEMBRANE ANTIGEN (PSMA) ANTIBODY DRUG CONJUGATES

METHODS AND SYSTEMS FOR MODULATING UNCONSCIOUSNESS OR ANESTHESIA IN A SUBJECT

METHODS AND COMPOSITIONS FOR INHIBITING OXIDATIVE STRESS

Method of Enhancing Gene Therapy by Targeting cGAS-STING Pathway

STING SENSITIZING AGENTS

PROTEIN DEGRADATION AGENT

METHODS OF TREATING OR PREVENTING STENT THROMBOSIS

MONOCLONAL ANTIBODY AND VACCINE TARGETING FILAMENTOUS BACTERIOPHAGE

IL-2/IL-15RBETAGAMMA AGONIST COMBINATION WITH ANTIBODY-DRUG CONJUGATES FOR TREATING CANCER

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY

Formulations and methods for skin care

USE OF LACTOBACILLUS PARACASEI BACTERIAL STRAINS IN THE TREATMENT OF NEWBORNS

COMPOSITION COMPRISING CORD BLOOD PLATELET RICH PLASMA (CB-PRP) IN PRE-FILLED SYRINGE AND USES THEREOF

Application of Bi-Phenols in Anti-ototoxicity and Hearing Protection

Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

COMPOSITIONS AND METHODS OF USE THEREOF

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

COMBINATION THERAPY FOR THE TREATMENT OF PAN-KRAS MUTATED CANCERS

[6R]-MTHF IN B6 ENHANCED 5-FU BASED CHEMOTHERAPY OF CARCINOMA

METHODS AND COMPOSITIONS FOR IMMUNE CONTROL THROUGH DICKKOPF-1

METHODS OF TREATING SWI/SNF DEREGULATED CANCERS

APPLICATION OF BENZISOQUINOLINE DIKETONE COMPOUND IN TREATMENT OF TUMOR

Antibody-drug conjugates and uses thereof

TREATMENT OF LOWER RESPIRATORY TRACT INFECTION WITH TRADIPITANT

MALEATE SALT OF THE FREE BASE OF N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)-PHENYL]-ACETAMIDE, PHARMACEUTICAL FORMULATIONS, METHODS OF MANUFACTURE AND USES THEREOF

METHODS FOR SELECTING AN INTRACRANIAL ATHEROSCLEROTIC DISEASE PATIENT FOR TREATMENT

METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE

Methods for treating heterotopic ossification

TREATMENT OF CIRCADIAN RHYTHM DISORDERS

Pharmaceutical combination for the treatment of a cancer

CAROTENOID SOLUTIONS AND USES THEREOF

CALCIUM LACTATE COMPOSITIONS AND METHODS OF USE

CENTRAL NERVOUS SYSTEM MODULATORS AS COVID-19 THERAPEUTICS

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

METHODS FOR PREPARING LIPOSOMAL FORMULATIONS

TRANSDERMAL DELIVERY FORMULATIONS AND METHODS FOR THE MANUFACTURE THEREOF

POLYFUNCTIONAL RADICAL SCAVENGER HYDROGEL FORMULATION

FORMULATIONS AND COMPOSITIONS FOR ORTHO- AND/OR RETRO-NASAL DELIVERY AND ASSOCIATED SYSTEMS, METHODS AND ARTICLES

Formulations and methods for skin care or hyaluronic acid synthesis

NUTRITIONAL COMPOSITION AND INFANT FORMULA FOR PROMOTING DE NOVO MYELINATION

VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

BETA-CATENIN (CTNNB1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

Bispecific T cell Engagers

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS

COMBINATION THERAPY AND RELATED METHODS

ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFECTIOUS DISEASES

ANTI-CD79BxCD3 BISPECIFIC ANTIBODY AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS BY TARGETING IGSF8

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTESTINAL CANCER

CONSTRUCTS HAVING A SIRP-ALPHA DOMAIN OR VARIANT THEREOF

STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION

Heteroaryl compounds as inhibitors of TYK2, composition and application thereof

NOVEL SMALL MOLECULE INHIBITORS OF PUS7 AND USES THEREOF

N-SUBSTITUTED FERROPORTIN INHIBITORS

COCRYSTALS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF TREATMENT INVOLVING SAME

PF LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS

ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS

PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

Drug Delivery Device with Cannula Having Bioactive Agent

A SHORTENED P63-PROTEIN DOMAIN TO ENHANCE HUMAN CARDIAC REPROGRAMMING

ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF

METHODS OF ANTIBODY PRODUCTION

PHOSPHOR-CONTAINING DRUG ACTIVATOR KIT

TARGETING 3-KETODIHYDROSPHINGOSINE REDUCTASE (KDSR) IN CANCER

INTERLEUKIN-12 VARIANTS AND METHODS OF USE

Isthmin Protein Therapeutics for the Treatment of Non-Alcoholic Fatty Liver Disease

ANTI-ANGIOGENIC TREATMENT USING ECHISTATIN WITH A BLOCKING PEPTIDE

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING MUCOSAL TISSUE DAMAGE OR DISEASE

COMPOSITIONS AND METHODS FOR TRANSPLANTATION OF COLON MICROBIOTA

METHODS OF TREATING CANCER

Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY

EMULSION FORMULATIONS

METHODS OF TREATING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) DYSFUNCTION

ORAL QUETIAPINE SUSPENSION FORMULATIONS WITH EXTENDED SHELF LIFE AND ENHANCED BIOAVAILABILITY

Use of NEP Inhibitors for the Treatment of Laminitis

USE OF NEP INHIBITORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DISORDERS

PYRIDINE DERIVATIVES WITH N-LINKED CYCLIC SUBSTITUENTS AS cGAS INHIBITORS

VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS

METHODS OF TREATING BRAIN CANCER

CALMODULIN INHIBITORS, CHK2 INHIBITORS AND RSK INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISORDERS AND RIBOSOMAPATHIES

METHODS AND COMPOSITIONS FOR TREATING VIRAL OR VIRALLY-INDUCED CONDITIONS

DISCOVERY OF A F-ATP SYNTHASE INHIBITOR FOR THE TREATMENT OF MYCOBACTERIUM ABSCESSUS DISEASES

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TUMOR, AND USE THEREOF

METHOD OF TREATMENT OF DEPRESSED PATIENTS WITH POOR COGNITION AND SELECTION OF OTHER PATIENTS BENEFITING FROM A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT

BISBENZYLISOQUINOLINES AS CONDITIONING AGENTS FOR IMMUNE THERAPY

BAK ACTIVATORS, PHARMACEUTICAL COMPOSITIONS, AND USES IN TREATING CANCER

HYDROXYCHLOROQUINE FORMULATIONS, DOSAGE FORMS, AND METHODS OF USE

THE USE OF BETA-HYDROXYBUTYRATES FOR THE TREATMENT OR PREVENTION OF ANEURYSMS AND DISSECTIONS

TARGETING SOX10+ BONE MARROW GLIAL CELLS FOR TREATING MYELOFIBROSIS

CANCER THERAPEUTIC AGENT

NON-STEROID ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION

CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND FORMULATION AND APPLICATION THEREOF

ULTRASOUND-RESPONSIVE AQUEOUS TWO-PHASE MICROCAPSULE DESIGN FOR ON-DEMAND PULSATILE DRUG RELEASE

COMPOSITIONS AND TREATMENTS FOR CORONAVIRUS INFECTIONS

METHODS OF TREATING COMPROMISED LUNG FUNCTION AND ASSESSING CLINICAL IMPROVEMENT

METHODS FOR SELECTING MELANOMA PATIENTS FOR THERAPY AND METHODS OF REDUCING OR PREVENTING MELANOMA METASTASIS

USE OF OLIGONUCLEOTIDES FOR INDIVIDUALS WITH RENAL IMPAIRMENT

ENTPD2 ANTIBODIES, COMBINATION THERAPIES, AND METHODS OF USING THE ANTIBODIES AND COMBINATION THERAPIES

COMPOSITIONS AND METHODS FOR TREATING ALPHA-SYNUCLEINOPATHIES

AGONISTS OF TYRO3 AS PROTECTION AGAINST PODOCYTE INJURY IN KIDNEY GLOMERULAR DISEASE

NIMBOLIDE ANALOGS AND METHODS OF USE THEREOF

Hydroquinazoline derivatives for the treatment of a disease or disorder

CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS

METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE

POWDER COMPOSITION

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

BIOLOGIC FOR THE TREATMENT OF CANCER

THERAPEUTIC COMPOSITION FOR USE IN THE TREATMENT OF COVID-19 AND OTHER CYTOKINE STORM ASSOCIATED DISORDERS

NON-HUMAN BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN (BPI) FOR THERAPY OF INFECTIONS

ROMIDEPSIN AS A THERAPEUTIC AGENT FOR NERVE-INJURY INDUCED NEUROPATHIC PAIN AND SPASTICITY

BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS

USE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA (PGC1ALPHA) AGONISTS TO IMPROVE EX VIVO EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS)

NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR USE IN THE TREATMENT OF SAPHO SYNDROME

A NON-CANONICAL SIGNALING ACTIVITY OF CGAMP TRIGGERS DNA DAMAGE RESPONSE SIGNALING

MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING

CO-CRYSTAL COMPOSITION AND ITS PHARMACEUTICAL USE

ACRYLAMIDE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST

Roflumilast formulations with an improved pharmacokinetic profile

Combination Therapy for Treating or Preventing Depression or Other Mood Diseases

SMALL MOLECULE INHIBITION OF DEUBIQUITINATING ENZYME JOSEPHIN DOMAIN CONTAINING 1 (JOSD1) AS A TARGETED THERAPY FOR LEUKEMIAS WITH MUTANT JANUS KINASE 2 (JAK2)

ANETHOLE TRITHIONE FOR THE TREATMENT OF VASCULITIDES

COMPOSITIONS AND METHODS FOR STIMULATING VENTILATORY AND/OR RESPIRATORY DRIVE

Soluble Guanylate Cyclase Activators for Cancer and Fibrosis Treatment

SUBSTITUTED ESTERS CONTAINING POLYOLS AND SACCHARIDES FOR TREATING HEPATOTOXICITY AND FATTY LIVER DISEASES

Use Of Methanol And Prodrugs Thereof In Therapy

FORMULATION AND METHOD FOR INCREASING ORAL BIOAVAILABILITY OF DRUGS

NANO- OR MICRO-EMULSION COMPOSITIONS AND METHODS OF USE THEREOF

MUCOADHESIVE OCULAR DELIVERY SYSTEM FOR THE TREATMENT OF GLAUCOMA

STENT FOR BLOOD VESSEL

ANTI-PLA2G2D CONSTRUCTS AND USES THEREOF

ANTI-BCMA ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

TIE2-BINDING AGENTS AND METHODS OF USE

COMPOSITIONS COMPRISING A T CELL REDIRECTION THERAPEUTIC AND A VLA-4 ADHESION PATHWAY INHIBITOR

COMPOSITIONS AND METHODS FOR TREATMENT OF RETINAL DEGENERATION

SARS-COV-2-SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE

MODULATION OF MAMMALIAN CELL LINEAGE BY SYNTHETIC IMMODULINS

NORA INHIBITORS AND METHODS OF USE

[1,3]Thiazolo[4,5-d]-pyrimidon-7-ones as inhibitors of NOX4

Inhibitors of human immunodeficiency virus replication, method of making and method of using thereof

CRYSTALLINE FORMS OF CEFTIBUTEN

Multicomponent Complexes, Including Salts, Crystalline Forms, and Hydrates and Solvates of ENT1 Inhibitors

NOVEL INHIBITORS OF AUTOTAXIN

Thioamide derivative and preparation method and application thereof

TRIAZINE DERIVATIVES FOR THE TREATMENT OF TUMOURS AND NEURODEGENERATIVE DISORDERS

PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

CRYSTALLINE (2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-(ETHOXYMETHYL)-4-(3-HYDROXYISOXAZOLE-5-CARBOXAMIDO)-2-METHYLPENTANOIC ACID AND USES THEREOF

GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS

Methods for making and using endoxifen

METHODS FOR DETECTING AND PREVENTING ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT

MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE

CATIONIC LIPID FOR COVALENT MODIFICATION OF PEPTIDES

CELLULAR THERAPIES FOR CANCER BY INHIBITION OF MONOCARBOXYLATE TRANSPORTER 11

COMPOSITIONS AND METHODS TO SUPPRESS TUMOR GROWTH IN BONE, PREVENT CACHECTIC MUSCLE LOSS, AND PRESERVE SKELETAL INTEGRITY

COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT

SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF

Pharmaceutical Compositions And Methods For Treating Neoplasia

MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING

PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS

BORATE COMPLEXES OF CHLOROGENIC ACID AND USES THEREOF

COMPOSITIONS COMPRISING A CONSTITUENT, DERIVATIVE OR EXTRACT OF CANNABIS

CONSTITUENT, DERIVATIVE OR EXTRACT OF CANNABIS IN A WATER SOLUBLE MATRIX

FORMULATIONS FOR THE TREATMENT OF RESPIRATORY DISORDERS

Fused Heterotetracyclic Antiviral Agents

COMPOUND USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

TREATMENT OF CANCER WITH A RAF INHIBITOR

MOMELOTINIB COMBINATION THERAPY

COMBINATION THERAPIES

USE OF COMBINATION THERAPY FOR TREATING CANCER

DOSAGE REGIMENS FOR PARP7 INHIBITORS

NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND ANTI-INTERFERON EFFECT

Small Molecule Targeting of BRD4 for Treatment of COVID-19

COMPOSITIONS AND METHODS FOR TREATING ANEMIA ASSOCIATED WITH A RIBOSOMAL DISORDER

METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD47-SIRPA THERAPEUTIC AGENT

SELECTIVE CDK9 INHIBITOR FOR THE TREATMENT OF A RAS MUTANT CANCER

METHOD OF ADMINISTRATION

ZINC ASCORBATE, HESPERIDIN, ARGININE, QUERCETIN AND CALCIDIOL CONTAINING COMPOSITIONS FOR SUPPORTING IMMUNE HEALTH

Bactericidal and virucidal pharmaceutical composition

TREATMENT OF BRAIN METASTASES AND CNS METASTASES USING ILLUDINS OR HYDROXYLUREAMETHYL ACYLFULVENE

METHOD FOR ATTENUATING NEUROINFLAMMATION, AMYLOIDOPATHY AND TAUOPATHY

METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES

DIAGNOSIS AND TREATMENT OF PANCREATIC CANCER

DEVICES AND METHODS FOR DIAGNOSISING THYROID MEDICAL CONDITIONS

MESENCHYMAL STEM CELL-DERIVED MICRORIBONUCLEIC ACID-MEDIATED TREATMENTS FOR THE PREVENTION AND TARGETED TREATMENT OF CANCER AND OTHER DISORDERS

VON WILLEBRAND FACTOR (VWF)-TARGETING AGENTS AND METHODS OF USING THE SAME

Compositions and Methods for Silencing MYOC Expression

PH20 polypeptide variants, formulations and uses thereof

Treatment Of Multiple Sclerosis And Neuromyelitis Optica

Use of Anti-EGFR/Anti-Met Antibody to Treat Gastric or Esophageal Cancer

ANTIBODIES AGAINST PD-L1

METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY

Advanced avatar dendritic cells

NON-HLA RESTRICTED T CELL VACCINE FOR TCR GAMMA ALTERNATE READING FRAME PROTEIN (TARP) PROTEIN EXPRESSING CANCERS

APPLICATION OF APOPTOSIS INHIBITOR 5 (API5) FOR EPITHELIAL RESTITUTION

COMPOSITIONS AND METHODS FOR TREATING AND/OR IDENTIFYING AN AGENT FOR TREATING HIV-1 INFECTIONS

METHOD FOR THE TREATMENT OF ALLERGIC RHINITIS

A PROCESS FOR THE PRODUCTION OF AMCIPATRICIN DIASCORBATE AND THE USE OF THE SAME FOR THE TREATMENT OF INVASIVE FUNGAL INFECTIONS RESISTANT TO TRADITIONAL ANTIFUNGAL AGENTS

Pharmaceutical Compound

COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT

INHIBITORS OF BRUTON'S TYROSINE KINASE

Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase

PHENYLPIPERIDINE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN

Human Antibodies To PD-1

PREPARATION METHOD AND APPLICATION OF A TARGETED PEPTIDE MODIFIED NANODRUG DELIVERY SYSTEM (PDC) WITH SPECIFIC BINDING TO THE NEUROTENSIN RECEPTOR (NTR)

COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE

COMPOSITIONS AND METHODS FOR SELECTIVELY MODULATING TREGS

METHODS FOR PREPARING COMPLEX FOR ENHANCING IMMUNE RESPONSE

COMPOSITIONS AND METHODS FOR TARGETED IMMUNOTHERAPY

POLYPEPTIDES FOR CANCER TREATMENT

Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

STABLE THERAPEUTIC COMPOSITIONS IN APROTIC POLAR SOLVENTS AND METHODS OF MANUFACTURING THE SAME

HALF-LIFE EXTENDING MOIETIES AND METHODS OF USING THE SAME

PHARMACEUTICAL COMPOSITION COMPRISING AN APL TYPE PEPTIDE

METHODS OF REDUCING NEUROPATHY AND NEUROPATHIC SYMPTOMS AND TREATING CANCER

PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEGENERATIVE DISEASES

PHARMACEUTICAL COMPOSITION AND METHOD FOR SUPPRESSING DEGENERATION

TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) TARGETING HBV

Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections

MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION

MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION

PHARMACEUTICAL COMPOSITION

METHODS OF DECREASING HEPARAN SULFATE EXPRESSION USING EXT1 INHIBITORS

COMPOSITION COMPRISING PIP4K2C INHIBITOR AS ACTIVE INGREDIENT FOR TREATMENT OF CANCER

PEPTIDE DRUG CONJUGATES

FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS

METHODS FOR THE TREATMENT OF ABNORMAL INVOLUNTARY MOVEMENT DISORDERS

OPHTHALMIC CREAM FORMULATIONS AND THEIR USES

APIXABAN FILM PRODUCT AND USES THEREOF

NOVEL ENANTIOMERS OF A SERIES OF ANTIVIRAL COMPOUNDS

EFFECTIVE TREATMENT OF DEPRESSION IN PATIENTS HAVING IMPAIRED LEARNING AND/OR MEMORY OR CERTAIN EEG CHARACTERISTICS WITH A BENZYLPIPERAZINE-AMINOPYRIDINE AGENT

USE OF PHARMACEUTICAL COMPOSITION COMPRISING CHLOROGENIC ACID IN PREPARATION OF DRUG FOR TREATING EARLY ALZHEIMER'S DISEASE

ORAL COMPOSITIONS COMPRISING KETAMINE COMBINED WITH SUBCUTANEAL OR INTRAVENOUS KETAMINE FOR USE IN THE TREATMENT, CONTROL OR PREVENTION OF DEPRESSIVE DISORDERS

MICROSPHERE-BASED DRUG DELIVERY PLATFORM FOR DELIVERY OF IMMUNOTHERAPEUTIC AGENTS

TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS

SUSTAINED RELEASE CANCER THERAPEUTICS FORMULATIONS

SMART DOSING FOR CANCER THERAPY

BIOMARKERS FOR CANCER AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR SENSITIZATION OF TUMOR CELLS TO IMMUNE THERAPY

CTLA-4 APTAMER CONJUGATES

OPTICAL TRANSMISSION SAMPLE HOLDER AND ANALYSIS, PARTICULARLY FOR HEMOGLOBIN

MESENCHYMAL STEM CELL-DERIVED EXOSOME DRUG DELIVERY FOR CANCER AND OTHER DISORDERS

Mammalian cell population and medicaments for cell therapies in humans and improved cell cultivation methods

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

ANTI-NPR1 ANTIBODIES AND USES THEREOF